Endometriosis Diagnostic
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
135
NCT05698212
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 14, 2022
Completion: Apr 10, 2023
NCT06662227
Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors
Phase: Early Phase 1
Role: Collaborator
Start: Oct 24, 2024
Completion: Dec 30, 2029
NCT06663046
Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma
Start: Jul 1, 2025
Loading map...